Medical and pharmacologic management of the HIV-infected child

C. Diaz*, C. Chantry, R. Yogev

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Pharmacologic intervention and medical support of the HIV-infected child have to be clearly focused on improving duality of life and decreasing the rate of disease progression. The optimal timing and agents will be defined as we find answers to crucial questions such as: How early to intervene? Should we have a single or multiple agent approach? Answers to these questions are critically needed. Well-designed and conducted clinical trials will shed light and needed data to answer these questions and will allow us to redefine recommendations for the near future.

Original languageEnglish (US)
Pages (from-to)395-420
Number of pages26
JournalImmunology and Allergy Clinics of North America
Issue number2
StatePublished - Jun 8 1995

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Medical and pharmacologic management of the HIV-infected child'. Together they form a unique fingerprint.

Cite this